Medical specialists from France tagged as investigators in clinical trials studying Mesothelioma
Total 13 results
-
Antoine ItalianoSeen in:
- Aquitaine, Bordeaux, Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest
- Bordeaux Cedex, Institut Bergonie
- Bordeaux, Bergonie Institute
- Bordeaux, Institut Bergonie
- Bordeaux, Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest
Trials:- NCT05009927 (Principal Investigator)
- NCT03906331 (Principal Investigator)
- NCT05440786 (Principal Investigator)
- NCT05269355 (Principal Investigator)
- NCT02834884 (Principal Investigator)
- NCT03157128 (Principal Investigator)
- NCT02029001 (Principal Investigator)
- NCT04104776 (Principal Investigator)
- NCT05920408 (Principal Investigator)
- NCT05999994 (Principal Investigator)
- NCT03475953 (Sub-Investigator)
Conditions:- C-KIT Mutation;
- Metastatic Gastrointestinal Stromal Tumor (GIST);
- Advanced Gastrointestinal Stromal Tumor (GIST);
- Breast Cancer;
- Pancreatic Cancer;
- Non Small Cell Lung Cancer;
- Colon Cancer;
- Medullary Thyroid Cancer;
- Papillary Thyroid Cancer;
- Other Solid Tumors With Evidence of Activating RET Alteration;
- Neoplasm Metastasis;
- Sarcoma, Ewing;
- Leiomyosarcoma;
- All Tumor Types;
- Non-Small Cell Lung Cancer;
- Any Solid Tumor;
- Malignant Solid Neoplasms;
- Lymphoma, T-Cell;
- Mesothelioma, Malignant;
- Advanced Solid Tumor;
- Endometrial Cancer;
- Diffuse Large B Cell Lymphoma;
- Ovarian Clear Cell Carcinoma;
- Prostatic Neoplasms, Castration-Resistant;
- Advanced Solid Tumours;
- Adolescent;
- Neoplasms;
- Child;
- Hepatocellular Carcinoma;
- Triple Negative Breast Cancer;
- Non-small Cell Lung Cancer;
- Soft-tissue Sarcoma;
- Urothelial Carcinoma;
- Thyroid Cancer;
- Gastro-enteropancreatic Neuroendocrine Tumor;
- Biliary Tract Cancer;
- HPV-Related Carcinoma;
- Solid Tumor, Adult;
- Mesotheliomas Pleural;
- GIST;
- Renal Carcinoma;
- Colorectal Cancer Not MSI-H or MMR-deficient;
- Oesophageal or Gastric Carcinoma
-
Arnaud ScherpereelSeen in:
- Lille, Centre Hospitalier Regional Universitaire de Lille
Trials:- NCT03610360 (Principal Investigator)
Conditions: -
Capucine BaldiniSeen in:
- Other, Villejuif Cedex, Institut Gustave Roussy
- Val De Marne, Villejuif, Centre de Lutte Contre le Cancer Gustave Roussy
- Villejuif Cedex, Institut Gustave Roussy
Trials:- NCT04586270 (Principal Investigator)
- NCT04665921 (Principal Investigator)
- NCT04042480 (Principal Investigator)
Conditions:- Advanced or Metastatic Solid Tumors;
- Uterine Cervical Neoplasms;
- Stomach Neoplasms;
- Colorectal Neoplasms;
- Esophageal Neoplasms;
- Ovarian Neoplasms;
- Endometrial Neoplasms;
- Pseudomyxoma Peritonei;
- Carcinoma, Non-Small Cell Lung;
- Gastroesophageal Junction Carcinoma;
- HER2 Negative Breast Neoplasms;
- Exocrine Pancreatic Adenocarcinoma;
- Appendiceal Adenocarcinoma;
- Colorectal Cancer;
- Non-small Cell Lung Cancer;
- Pancreatic Ductal Adenocarcinoma;
- Cutaneous Melanoma;
- Pleural Mesothelioma
-
Caroline RobertSeen in:
- Other, Villejuif Cedex, Institut Gustave Roussy
- Villejuif, Gustave Roussy
Trials:- NCT05571839 (Principal Investigator)
- NCT05529316 (Principal Investigator)
- NCT03235245 (Principal Investigator)
-
Cyril AbdeddaimSeen in:
- Lille, Centre OSCAR LAMBRET
- Lille, Oscar Lambret Center
Trials:- NCT03088059 (Principal Investigator)
- NCT04104776 (Principal Investigator)
-
Estelle Guerdoux, PhDSeen in:
- Hérault, Montpellier, ICM
Trials:- NCT04024917 (Principal Investigator)
-
Lauriane EberstSeen in:
- Strasbourg, Strasbourg Europe Institut of Cancerology
Trials:- NCT04104776 (Principal Investigator)
-
Mehdi BrahmiSeen in:
- Lyon, Centre Leon Berard
- Lyon, Leon Berard Center
- Rhone, Lyon cedex 08, Centre Leon Berard
Trials:- NCT04104776 (Principal Investigator)
- NCT04927260 (Principal Investigator)
- NCT04936178 (Principal Investigator)
-
Sophie Cousin, MDSeen in:
- Bordeaux Cedex, Institut Bergonie
- Bordeaux, EDOG - Institut Bergonie - PPDS
- Bordeaux, Institut Bergonie
- Bordeaux, Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest
Trials:- NCT05403385 (Principal Investigator)
- NCT04880382 (Principal Investigator)
- NCT03475953 (Principal Investigator)
- NCT05668585 (Principal Investigator)
- NCT05027867 (Principal Investigator)
Conditions:- Metastatic NSCLC;
- Stage III NSCLC;
- Non Small Cell Lung Cancer;
- Hepatocellular Carcinoma;
- Triple Negative Breast Cancer;
- Non-small Cell Lung Cancer;
- Soft-tissue Sarcoma;
- Urothelial Carcinoma;
- Thyroid Cancer;
- Gastro-enteropancreatic Neuroendocrine Tumor;
- Biliary Tract Cancer;
- HPV-Related Carcinoma;
- Solid Tumor, Adult;
- Mesotheliomas Pleural;
- GIST;
- Renal Carcinoma;
- Colorectal Cancer Not MSI-H or MMR-deficient;
- Oesophageal or Gastric Carcinoma;
- Melanoma;
- NSCLC;
- Solid Tumors;
- CRC;
- ATC;
- Small Cell Lung Carcinoma;
- Small-cell Lung Cancer;
- Small Cell Lung Cancer Extensive Stage;
- Small Cell Lung Cancer Recurrent
-
Thomas GastinneSeen in:
- Loire-Atlantique, Nantes, CHU de Nantes - Hematologie
- Loire-Atlantique, Nantes, CHU de Nantes - Service d'Hématologie Clinique Place Alexis Ricordeau
- Loire-Atlantique, Nantes, Service d'Hématologie Clinique Place Alexis Ricordeau
- Nantes Cedex 1, Centre Hospitalier Universitaire de Nantes - L' Hopital l'hôtel-Dieu
- Nantes, CHU Nantes
- Nantes, Hospital North
- Nantes, Nantes University Hospital Center - Hotel Dieu Hospital
- Nantes, Nantes University Hospital Center - Hotel Dieu Hospital (Satellite)
- Other, Nantes cedex 1, Centre Hospitalier Universitaire Nantes-Hotel Dieu
Trials:- NCT04662255 (Principal Investigator)
- NCT04404283 (Principal Investigator)
- NCT04104776 (Principal Investigator)
- NCT04224493 (Principal Investigator)
- NCT04446962 (Principal Investigator)
Conditions:- Lymphoma, Mantle-Cell;
- Diffuse Large B-cell Lymphoma;
- Lymphoma, T-Cell;
- Mesothelioma, Malignant;
- Advanced Solid Tumor;
- Endometrial Cancer;
- Diffuse Large B Cell Lymphoma;
- Ovarian Clear Cell Carcinoma;
- Prostatic Neoplasms, Castration-Resistant;
- Follicular Lymphoma;
- Relapsed/Refractory Follicular Lymphoma;
- Refractory Follicular Lymphoma;
- Lymphoma, Large B-Cell, Diffuse;
- Central Nervous System Neoplasms, Primary
-
Vincent Ribrag, MDSeen in:
- Val De Marne, Villejuif cedex, Institut Gustave Roussy
- Villejuif, Gustave Roussy
Trials:- NCT05176691 (Principal Investigator)
- NCT04104776 (Principal Investigator)
Conditions:- Follicular Lymphoma;
- Waldenstrom Macroglobulinemia;
- Lymphoplasmacytic Lymphoma;
- NHL;
- DLBCL;
- Richter Syndrome;
- CLL/SLL;
- MCL;
- MZL;
- Lymphoma, T-Cell;
- Mesothelioma, Malignant;
- Advanced Solid Tumor;
- Endometrial Cancer;
- Diffuse Large B Cell Lymphoma;
- Ovarian Clear Cell Carcinoma;
- Prostatic Neoplasms, Castration-Resistant
Clinical Trials on Mesothelioma
-
University of ChicagoNational Cancer Institute (NCI)Active, not recruitingBiphasic Mesothelioma | Epithelioid Mesothelioma | Peritoneal Malignant Mesothelioma | Pleural Biphasic Mesothelioma | Pleural Epithelioid Mesothelioma | Pleural Malignant Mesothelioma | Pleural Sarcomatoid Mesothelioma | Recurrent Peritoneal Malignant Mesothelioma | Recurrent Pleural Malignant Mesothelioma and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Malignant Mesothelioma | Epithelial Mesothelioma | Sarcomatous Mesothelioma | Stage IA Malignant Mesothelioma | Stage IB Malignant Mesothelioma | Stage II Malignant Mesothelioma | Stage III Malignant Mesothelioma | Stage IV Malignant MesotheliomaUnited States
-
National Cancer Institute (NCI)TerminatedEpithelioid Mesothelioma | Sarcomatoid Mesothelioma | Stage IV Pleural Mesothelioma | Recurrent Malignant Mesothelioma | Stage II Pleural Mesothelioma | Stage III Pleural MesotheliomaUnited States
-
National Cancer Institute (NCI)CompletedCediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By SurgeryRecurrent Malignant Mesothelioma | Advanced Malignant Mesothelioma | Epithelial Mesothelioma | Sarcomatous Mesothelioma | Localized Malignant MesotheliomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Malignant Mesothelioma | Advanced Malignant Mesothelioma | Epithelial Mesothelioma | Sarcomatous Mesothelioma | Localized Malignant MesotheliomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingBiphasic Mesothelioma | Epithelioid Mesothelioma | Stage III Pleural Malignant Mesothelioma AJCC v7 | Stage I Pleural Malignant Mesothelioma AJCC v7 | Stage IA Pleural Malignant Mesothelioma AJCC v7 | Stage IB Pleural Malignant Mesothelioma AJCC v7 | Stage II Pleural Malignant Mesothelioma AJCC...United States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Malignant Mesothelioma | Stage IA Malignant Mesothelioma | Stage IB Malignant Mesothelioma | Stage II Malignant Mesothelioma | Stage III Malignant Mesothelioma | Stage IV Malignant MesotheliomaUnited States
-
ProgenaBiomeRecruitingMesothelioma | Mesotheliomas Pleural | Mesothelioma Peritoneum | Mesothelioma Malignant | Mesothelioma; Lung | Mesothelioma; Liver | Mesothelioma; OmentumUnited States
-
National Cancer Institute (NCI)Active, not recruitingEpithelioid Mesothelioma | Pleural Malignant Mesothelioma | Sarcomatoid Mesothelioma | Recurrent Malignant MesotheliomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Malignant Mesothelioma | Advanced Malignant Mesothelioma | Epithelial Mesothelioma | Sarcomatous MesotheliomaUnited States